FWM
TEVA icon

FSA Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

FSA Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.02K Hold
100
– – ﹤0.01% 497
2025
Q2 		$1.68K Hold
100
– – ﹤0.01% 482
2025
Q1 		$1.54K Hold
100
– – ﹤0.01% 450
2024
Q4 		$2.2K Hold
100
– – ﹤0.01% 478
2024
Q3 		$1.8K Buy
+100
New +$1.75K ﹤0.01% 498
2024
Q1 		$1.41K Hold
100
– – ﹤0.01% 561
2023
Q4 		$1K Buy
+100
New +$934 ﹤0.01% 570
2020
Q3 		– Sell
-100
Closed -$1K – 320
2020
Q2 		$1K Hold
100
– – ﹤0.01% 379
2020
Q1 		$1K Hold
100
– – ﹤0.01% 374
2019
Q4 		$1K Buy
+100
New +$893 ﹤0.01% 450

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

FSA Wealth Management's TEVA Position: Q3 2025 in Review

FSA Wealth Management held its Teva Pharmaceuticals (TEVA) position steady in Q3 2025 at 100 shares worth $2.02K. The position accounts for ﹤0.01% of the portfolio, ranked #497.

FSA Wealth Management first reported a position in TEVA in Q4 2019 and has held it in 10 quarters since. The position peaked at $2.2K in Q4 2024. 550 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

  • FSA Wealth Management held 100 shares of Teva Pharmaceuticals worth $2.02K as of Q3 2025.
  • FSA Wealth Management left its Teva Pharmaceuticals share count unchanged in Q3 2025.
  • Teva Pharmaceuticals made up ﹤0.01% of FSA Wealth Management's portfolio in Q3 2025, its #497 holding.
  • FSA Wealth Management first reported a position in Teva Pharmaceuticals in Q4 2019 and has held it in 10 quarters since.
  • FSA Wealth Management's Teva Pharmaceuticals position peaked at $2.2K in Q4 2024.
  • 550 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2025.

Based on FSA Wealth Management's 13F filing for Q3 2025, filed 17 Nov 2025.